Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul;6(3):031403.
doi: 10.1117/1.JMI.6.3.031403. Epub 2018 Dec 22.

Comparison of screening full-field digital mammography and digital breast tomosynthesis technical recalls

Affiliations

Comparison of screening full-field digital mammography and digital breast tomosynthesis technical recalls

Lonie R Salkowski et al. J Med Imaging (Bellingham). 2019 Jul.

Abstract

Enhancing quality using the inspection program (EQUIP) augments the FDA/MQSA program ensuring image quality review and implementation of corrective processes. We compared technical recalls between digital breast tomosynthesis (DBT) and full-field digital mammography (FFDM). Prospectively recorded technical recalls of consecutive screening mammograms (10/2013 - 12/2017) were compared for imaging modality [FFDM, DBT + FFDM, DBT + synthesized mammography (SynM)], images requested, and indication(s) (motion, positioning, technical/artifact). Chi-squared tests evaluated statistical significance between proportions. Of 48,324 screening mammograms, 277 (0.57%) patients were recalled for 360 indications with 371 repeated views. DBT exams had significantly less recalls compared to FFDM ( X 2 = 25.239 ; p = 0 < 0.001 ). 98 (27.2%) recalls were for motion, 192 (53.3%) positioning, and 70 (19.4%) technique/artifacts. Theses indications for technical recall were compared for FFDM, DBT + FFDM, and DBT + SynM. There were significant differences in the indications for technical recall prior to and after implementing DBT + SynM ( X 2 = 18.719 ; p < 0.001 ). Technical recalls declined significantly with the inclusion of DBT (SynM/FFDM) compared to FFDM alone. Recalls for motion demonstrated the greatest decrease. Positioning remains a dominant factor for technical recall regardless of modality, supporting the opportunity for continued technologist education in positioning to decrease technical recalls.

Keywords: EQUIP; FFDM; breast imaging; digital mammography; technical recall; tomosynthesis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Illustration of positioning criteria of the breast. (a) Left MLO view demonstrating the pectoralis muscle, nipple in profile, and the IMF. (b) Left CC view demonstrating the nipple in profile and centered. The white line indicates the PNL comparison between the CC and MLO views.
Fig. 2
Fig. 2
Distribution of the technical recalls per number of exams performed over the study by technologists. Each technologist is represented by a data point.
Fig. 3
Fig. 3
Distribution of the technical recalls per number of exams interpreted over the study by radiologists. Each radiologist is represented by a data point.
Fig. 4
Fig. 4
Distribution of indications for technical recalls for FFDM and DBT.
Fig. 5
Fig. 5
Changes in the indications for technical recall prior to and after the implementation of SynM with DBT imaging.
Fig. 6
Fig. 6
(a) FFDM of the left MLO axillary region. The white arrow is pointing to tiny white “calcifications” in the axillary region, which may represent either calcifications or deodorant artifact. Breast tissue extends into the axilla; thus, this may be clinically important. (b) Left MLO DBT image of the same patient. These tiny white “calcifications” are only seen on the image for slice 1 (long white arrow pointing to slice number indicator), thus signifying that they are located on the skin surface and can be disregarded as artifact.

Similar articles

Cited by

References

    1. Smith R. A., et al. , “The randomized trials of breast cancer screening: what have we learned,” Radiol. Clin. North Am. 42, 793–806 (2004).10.1016/j.rcl.2004.06.014 - DOI - PubMed
    1. National Cancer Institute, “Breast cancer screening (PDQ®)– health professional version,” 2018, https://www.cancer.gov/types/breast/hp/breast-screening-pdq#link/_93_toc (18 February 2018).
    1. Howlader N., et al., Eds., SEER Cancer Statistics Review, 1975-2014, National Cancer Institute, Bethesda, MD, https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.
    1. Elkin E. B., et al. , “The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975–1999,” Cancer 104(6), 1149–1157 (2005).CANCAR10.1002/(ISSN)1097-0142 - DOI - PubMed
    1. Broeders M., et al. , “The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies,” J. Med. Screening 19(1 Suppl), 14–25 (2012).10.1258/jms.2012.012078 - DOI - PubMed